Last 12 months
Inside the activity.
9 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2022 Filed Nov 4, 2022 19:27 UTC |
Brooks Michael JPresident
|
GrantCommon Share Warrants (Right to Buy) · Derivative | 2,119 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001654954-22-014747 · section16.xml · derivative · entry 3 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,119 Underlying: Common Shares · 2,119 shares Expires not disclosed F3 · security: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F1 · price: The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F3 · derivative.exercise_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F3 · derivative.expiration_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 19:27 UTC |
Brooks Michael JPresident
|
GrantCommon Share Warrants (Right to Buy) · Derivative | 2,119 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001654954-22-014747 · section16.xml · derivative · entry 2 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,119 Underlying: Common Shares · 2,119 shares Expires not disclosed F2 · security: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F1 · price: The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F2 · derivative.exercise_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F2 · derivative.expiration_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 19:27 UTC |
Brooks Michael JPresident
|
GrantCommon Shares | 4,239 | $1.13 | $4,768.88 |
DisclosureSEC source: 0001654954-22-014747 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,480 F1 · price: The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 19:27 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
GrantCommon Share Warrants (Right to Buy) · Derivative | 4,444 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001654954-22-014746 · section16.xml · derivative · entry 3 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 4,444 Underlying: Common Shares · 4,444 shares Expires not disclosed F3 · security: Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F1 · price: The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F3 · derivative.exercise_date: Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F3 · derivative.expiration_date: Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 19:27 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
GrantCommon Share Warrants (Right to Buy) · Derivative | 4,444 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001654954-22-014746 · section16.xml · derivative · entry 2 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 4,444 Underlying: Common Shares · 4,444 shares Expires not disclosed F2 · security: Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F1 · price: The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F2 · derivative.exercise_date: Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F2 · derivative.expiration_date: Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 19:27 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
GrantCommon Shares | 8,888 | $1.13 | $9,999.00 |
DisclosureSEC source: 0001654954-22-014746 · section16.xml · nonDerivative · entry 1 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 10,715 F1 · price: The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 13:38 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 20,000 | $1.60 | $32,078.00 |
DisclosureSEC source: 0001654954-22-009259 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,812 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.52 to $1.6622. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 29, 2022 Filed Jun 30, 2022 15:23 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 3,000 | $1.49 | $4,482.90 |
DisclosureSEC source: 0001654954-22-009005 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,241 Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 12:30 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 3,000 | $1.61 | $4,816.50 |
DisclosureSEC source: 0001654954-22-008536 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,241 Read SEC document |
| May 27, 2022 Filed May 31, 2022 09:00 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 5,000 | $1.92 | $9,599.00 |
DisclosureSEC source: 0001654954-22-007684 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,812 Read SEC document |
| May 25, 2022 Filed May 26, 2022 16:29 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 3,500 | $1.74 | $6,090.00 |
DisclosureSEC source: 0001654954-22-007559 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,241 Read SEC document |
| May 24, 2022 Filed May 25, 2022 12:13 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 2,000 | $1.80 | $3,599.60 |
DisclosureSEC source: 0001654954-22-007509 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,812 Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 10:56 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 2,000 | $2.99 | $5,971.60 |
DisclosureSEC source: 0001654954-22-004413 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,812 Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 10:52 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 2,000 | $3.05 | $6,098.20 |
DisclosureSEC source: 0001654954-22-004245 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,812 Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 12:47 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 2,000 | $3.02 | $6,033.60 |
DisclosureSEC source: 0001654954-22-004118 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,812 Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 22:52 UTC |
Chao Jennifer MDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001654954-22-004197 · section16.xml · derivative · entry 1 Chao Jennifer M · CIK 0001639625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2032-03-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 10:27 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 2,000 | $3.85 | $7,699.20 |
DisclosureSEC source: 0001654954-22-003483 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,812 Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 11:26 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 1,603 | $3.26 | $5,232.19 |
DisclosureSEC source: 0001654954-22-003409 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,812 Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 11:26 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 397 | $3.25 | $1,290.17 |
DisclosureSEC source: 0001654954-22-003409 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,209 Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 11:17 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 2,000 | $2.80 | $5,598.00 |
DisclosureSEC source: 0001654954-22-003224 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,812 Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 16:44 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 1,250 | $2.79 | $3,486.63 |
DisclosureSEC source: 0001654954-22-003144 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,741 Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 13:59 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 5,000 | $3.06 | $15,294.50 |
DisclosureSEC source: 0001654954-22-003095 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,812 Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 13:59 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 2,000 | $3.18 | $6,357.60 |
DisclosureSEC source: 0001654954-22-003095 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,812 Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 16:10 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 1,000 | $3.22 | $3,222.90 |
DisclosureSEC source: 0001654954-22-002936 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,491 Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 11:10 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 1,500 | $3.05 | $4,569.60 |
DisclosureSEC source: 0001654954-22-002850 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548,812 Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 16:06 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 1,250 | $2.90 | $3,621.88 |
DisclosureSEC source: 0001654954-22-002765 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,491 Read SEC document |
| February 28, 2022 Filed Mar 7, 2022 19:41 UTC |
JOHNSON LORIN KDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002656 · section16.xml · derivative · entry 1 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Shares · 11,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| February 28, 2022 Filed Mar 8, 2022 00:53 UTC |
MacDonald Sean ArthurDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002659 · section16.xml · derivative · entry 1 MacDonald Sean Arthur · CIK 0001778981 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Shares · 11,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| February 28, 2022 Filed Mar 8, 2022 00:40 UTC |
Sistilli CarloDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002654 · section16.xml · derivative · entry 1 Sistilli Carlo · CIK 0001777988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Shares · 11,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| February 28, 2022 Filed Mar 8, 2022 00:56 UTC |
Pay Paul WilliamDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002660 · section16.xml · derivative · entry 1 Pay Paul William · CIK 0001778480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Shares · 11,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| February 28, 2022 Filed Mar 8, 2022 00:40 UTC |
OAKES FRANK R.Director
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002655 · section16.xml · derivative · entry 1 OAKES FRANK R. · CIK 0001620188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2022-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| February 28, 2022 Filed Mar 8, 2022 00:40 UTC |
Brooks Michael JPresident
|
GrantStock Option (right to buy) · Derivative | 43,500 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002653 · section16.xml · derivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500 Underlying: Common Shares · 43,500 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| February 28, 2022 Filed Mar 8, 2022 00:40 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 43,500 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002652 · section16.xml · derivative · entry 1 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500 Underlying: Common Shares · 43,500 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| February 28, 2022 Filed Mar 8, 2022 00:37 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 49,000 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002646 · section16.xml · derivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,000 Underlying: Common Shares · 49,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 17:04 UTC |
JOHNSON LORIN KDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004638 · section16.xml · derivative · entry 1 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:47 UTC |
MacDonald Sean ArthurDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004623 · section16.xml · derivative · entry 1 MacDonald Sean Arthur · CIK 0001778981 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 20,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:53 UTC |
Sistilli CarloDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004626 · section16.xml · derivative · entry 1 Sistilli Carlo · CIK 0001777988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 20,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 21:04 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004637 · section16.xml · derivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Shares · 120,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 21:01 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004635 · section16.xml · derivative · entry 1 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Shares · 80,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 21:00 UTC |
Brooks Michael JPresident
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004632 · section16.xml · derivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Shares · 80,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:57 UTC |
Pay Paul WilliamDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004630 · section16.xml · derivative · entry 1 Pay Paul William · CIK 0001778480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 20,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:55 UTC |
van der Velden PeterDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004628 · section16.xml · derivative · entry 1 van der Velden Peter · CIK 0001778046 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 20,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:49 UTC |
OAKES FRANK R.Director
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004624 · section16.xml · derivative · entry 1 OAKES FRANK R. · CIK 0001620188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 20,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 12 months beginning on the Grant Date. Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 11:44 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 3,000 | $5.25 | $15,750.00 |
DisclosureSEC source: 0001654954-21-003334 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,312 Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 15:44 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 3,500 | $5.19 | $18,165.00 |
DisclosureSEC source: 0001654954-21-003333 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241 Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 14:43 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 5,000 | $5.16 | $25,800.00 |
DisclosureSEC source: 0001654954-21-003274 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,312 Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 18:56 UTC |
Brooks Michael JPresident
|
PurchaseCommon stock | 4,500 | $5.08 | $22,860.00 |
DisclosureSEC source: 0001654954-21-003279 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,741 Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 00:40 UTC |
OAKES FRANK R.Director
|
SaleCommon Shares | 6,165 | $7.25 | $44,696.25 |
DisclosureSEC source: 0001654954-21-001837 · section16.xml · nonDerivative · entry 2 OAKES FRANK R. · CIK 0001620188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 00:40 UTC |
OAKES FRANK R.Director
|
SaleCommon Shares | 1,827 | $7.25 | $13,245.75 |
DisclosureSEC source: 0001654954-21-001837 · section16.xml · nonDerivative · entry 1 OAKES FRANK R. · CIK 0001620188 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Read SEC document |
| November 09, 2020 Filed Nov 9, 2020 18:01 UTC |
JOHNSON LORIN KDirector
|
OtherCommon Share Warrants (Right to Buy) · Derivative | 4,262 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-012045 · section16.xml · derivative · entry 2 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 4,262 shares Expires 2020-11-08 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.